Multiple Myeloma: Diagnosis and Treatment

Area of Science:

• Hematology
• Oncology
• Clinical Medicine

Background:

• Multiple myeloma diagnosis and treatment paradigms have undergone substantial evolution over the last decade.
• Updated disease definitions incorporate specific biomarkers alongside traditional markers of end-organ damage.

Purpose of the Study:

• To review the current diagnostic criteria for multiple myeloma.
• To outline the updated staging system integrating tumor burden and disease biology.
• To summarize recent therapeutic advancements and their impact on patient outcomes.

Main Methods:

• Review of recent literature and clinical guidelines.
• Analysis of updated diagnostic markers and staging systems.
• Summary of newly approved and investigational therapies for multiple myeloma.

Main Results:

• Revised diagnostic criteria now include highly specific biomarkers.
• The staging system has been updated to reflect tumor burden and disease biology.
• Therapeutic advances have led to significant improvements in overall survival.

Conclusions:

• The current approach to multiple myeloma diagnosis, prognosis, and management is significantly enhanced by recent advances.
• Novel therapeutic agents have markedly improved patient survival.
• This review provides an updated overview for clinicians managing multiple myeloma.